Insider Transactions in Q1 2021 at Streamline Health Solutions Inc. (STRM)
Insider Transaction List (Q1 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 17
2021
|
Thomas J. Gibson Former Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
7,407
-1.98%
|
$14,814
$2.26 P/Share
|
|
Mar 17
2021
|
William George Garvis SVP & COO |
SELL
Payment of exercise price or tax liability
|
Direct |
14,874
-2.51%
|
$29,748
$2.26 P/Share
|
|
Mar 17
2021
|
Randolph Salisbury SVP,Chief Sales & Mktg Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
7,525
-2.17%
|
$15,050
$2.26 P/Share
|
|
Mar 04
2021
|
Wyche T Green Iii Director |
BUY
Grant, award, or other acquisition
|
Direct |
150,000
+18.71%
|
-
|
|
Mar 04
2021
|
Thomas J. Gibson Former Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
100,000
+21.09%
|
-
|
|
Mar 04
2021
|
William George Garvis SVP & COO |
BUY
Grant, award, or other acquisition
|
Direct |
100,000
+25.25%
|
-
|
|
Mar 04
2021
|
Randolph Salisbury SVP,Chief Sales & Mktg Officer |
BUY
Grant, award, or other acquisition
|
Direct |
100,000
+22.41%
|
-
|
|
Mar 02
2021
|
Tamarack Global Healthcare Fund, L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
625,000
+11.25%
|
$625,000
$1.6 P/Share
|
|
Mar 02
2021
|
Tamarack Global Healthcare Fund, L.P. > 10% Shareholder |
BUY
Grant, award, or other acquisition
|
Direct |
625,000
+12.89%
|
$625,000
$1.6 P/Share
|
|
Mar 02
2021
|
Wyche T Green Iii Director |
BUY
Grant, award, or other acquisition
|
Indirect |
250,000
+50.0%
|
$250,000
$1.6 P/Share
|
|
Mar 02
2021
|
Jonathan R Phillips Director |
BUY
Grant, award, or other acquisition
|
Indirect |
62,500
+46.3%
|
$62,500
$1.6 P/Share
|
|
Mar 02
2021
|
Judith Starkey Director |
BUY
Grant, award, or other acquisition
|
Indirect |
62,500
+50.0%
|
$62,500
$1.6 P/Share
|
|
Mar 02
2021
|
Justin John Ferayorni Director |
BUY
Grant, award, or other acquisition
|
Indirect |
625,000
+50.0%
|
$625,000
$1.6 P/Share
|
|
Mar 02
2021
|
Kenan Lucas Director |
BUY
Grant, award, or other acquisition
|
Indirect |
625,000
+13.61%
|
$625,000
$1.6 P/Share
|
|
Feb 01
2021
|
Randolph Salisbury SVP,Chief Sales & Mktg Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
8,850
-3.47%
|
$17,700
$2.02 P/Share
|
|
Jan 29
2021
|
William George Garvis SVP & COO |
SELL
Payment of exercise price or tax liability
|
Direct |
11,683
-5.63%
|
$11,683
$1.85 P/Share
|
|
Jan 29
2021
|
Thomas J. Gibson Former Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,921
-1.03%
|
$2,921
$1.85 P/Share
|
|
Jan 29
2021
|
Randolph Salisbury SVP,Chief Sales & Mktg Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,921
-1.13%
|
$2,921
$1.85 P/Share
|